Osteopontin, a possible modulator of cancer stem cells and their malignant niche

OncoImmunology

Volumn 2, Issue 5, 2013, Pages

  Rao, Guanhua ^a   Du, Lei ^b   Chen, Quan ^a,b  

^a NANKAI UNIVERSITY   (China)

^b INSTITUTE OF ZOOLOGY   (China)

Author keywords

Cancer stem cells; CD44; Niche; Osteopontin; Tumor associated macrophages

Indexed keywords

HERMES ANTIGEN; INTEGRIN; OSTEOPONTIN;

ARTICLE; CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENICITY; CELL COMPARTMENTALIZATION; CELL CONTACT; CELL DIFFERENTIATION; CELL RENEWAL; COLORECTAL CANCER; HUMAN; INTRACELLULAR SIGNALING; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; STEM CELL NICHE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT;

EID: 84886945010     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.24169     Document Type: Article

References (10)

1. Li L, Neaves WB. Normal stem cells and cancer stem cells: the niche matters. Cancer Res 2006; 66:4553-7; PMID:16651403; http://dx.doi.org/10.1158/0008-5472.CAN-05-3986
2. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141:39-51; PMID:20371344; http://dx.doi.org/10.1016/j. cell.2010.03.014
3. Rao G, Wang H, Li B, Huang L, Xue D, Wang X, et al. Reciprocal interactions between tumor-associated macrophages and CD44-positive cancer cells via osteopontin/CD44 promote tumorigenicity in colorectal cancer. Clin Cancer Res 2013; 19:785-97; PMID:23251004
4. Rangaswami H, Bulbule A, Kundu GC. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol 2006; 16:79-87; PMID:16406521; http://dx.doi.org/10.1016/j.tcb.2005.12.005
5. Johnston NI, Gunasekharan VK, Ravindranath A, O'Connell C, Johnston PG, El-Tanani MK. Osteopontin as a target for cancer therapy. Front Biosci 2008; 13:4361-72; PMID:18508515; http://dx.doi. org/10.2741/3009
6. Anborgh PH, Mutrie JC, Tuck AB, Chambers AF. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment. J Cell Mol Med 2010; 14:2037-44; PMID:20597997; http://dx.doi. org/10.1111/j.1582-4934.2010.01115.x
7. Teramoto H, Castellone MD, Malek RL, Letwin N, Frank B, Gutkind JS, et al. Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12. Oncogene 2005; 24:489-501; PMID:15516973; http://dx.doi. org/10.1038/sj.onc.1208209
8. Das R, Mahabeleshwar GH, Kundu GC. Osteopontin stimulates cell motility and nuclear factor kappaBmediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells. J Biol Chem 2003; 278:28593-606; PMID:12771144; http://dx.doi.org/10.1074/jbc. M303445200
9. Atai NA, Bansal M, Lo C, Bosman J, Tigchelaar W, Bosch KS, et al. Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma. Immunology 2011; 132:39-48; PMID:20722758; http://dx.doi.org/10.1111/j.1365-2567.2010.03335.x
10. Wai PY, Guo L, Gao C, Mi Z, Guo H, Kuo PC. Osteopontin inhibits macrophage nitric oxide synthesis to enhance tumor proliferation. Surgery 2006; 140:132-40; PMID:16904962; http://dx.doi. org/10.1016/j.surg.2006.02.005